Latest Regulatory Filings News

DroneShield Limited has clarified the recent sharp decline in its share price, attributing the market movement to disclosed director share disposals rather than any undisclosed material information.

Anteris Technologies has gained FDA approval to start patient recruitment in the US for its pivotal PARADIGM Trial, following initial European regulatory success. The company advances manufacturing and clinical readiness as it pushes toward key regulatory milestones.

Mt Malcolm Mines NL has suspended trading of its M2MOA securities pending regulatory compliance, signaling a cautious pause for investors.

Coronado Global Resources posted a $109.5 million net loss for Q3 2025 amid subdued metallurgical coal markets and announced a proposed refinancing deal with Stanwell Corporation to strengthen its financial position.

Optiscan Imaging has entered a three-year strategic collaboration with Australian Clinical Labs to validate and deploy its InForm™ digital pathology platform, aiming to transform diagnostic workflows with real-time tissue analysis.

ALS Limited has responded to an ASX inquiry regarding the delayed lodgement of key disclosure documents related to performance rights granted to director Malcolm Deane, attributing the delay to human error and outlining steps to reinforce compliance.

ReNerve Limited is scaling up its clinical trial for the NervAlign® Nerve Cuff following promising interim results that show significant pain reduction in nerve repair patients. The expanded study aims to solidify evidence for broader regulatory approval and market adoption.

Imagion Biosystems reports encouraging findings from its Wayne State University collaboration, supporting a lower dose for its MagSense® HER2 imaging agent ahead of a planned FDA IND submission in Q4 2025.

Savannah Goldfields Limited has explained the late filing of a director’s interest notice, attributing it to an oversight during an entitlement offer. The company affirms its compliance processes remain robust despite the delay.

Black Dragon Gold has withdrawn its application to classify the Salave Gold Project as a Project of Strategic Interest in Asturias, Spain, planning a stronger resubmission backed by legal clarity and community support.

Locate Technologies has dispatched its Scheme Booklet to shareholders, outlining the proposed acquisition by Locate NZ and urging a vote in favour at the upcoming virtual meeting.

Merino & Co. initiates a new chapter with leadership changes and a strategic partnership to enter China’s premium apparel market, while investing heavily in growth during Q1 FY26.